Literature DB >> 11809870

Cannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity.

Tong-Rong Jan1, Gautham K Rao, Norbert E Kaminski.   

Abstract

It has been demonstrated previously that cannabinol (CBN) differentially modulates interleukin-2 (IL-2) protein secretion by T cells with a corresponding change in extracellular signal-regulated kinase activity. The objective of the present studies was to further investigate the molecular mechanism by which CBN enhances IL-2 gene expression using the EL4 T cell line. We demonstrate here that steady-state IL-2 mRNA expression was significantly enhanced by CBN in a concentration-dependent manner in EL4 cells activated with suboptimal concentrations of phorbol-12-myristate-13-acetate (2-10 nM). Concordantly, a marked increase was observed in nuclear factor of activated T cells (NF-AT) DNA binding activity to the IL-2 distal NF-AT site, but not to nuclear factor for immunoglobulin kappa chain in B cells or activator protein 1 motifs. Transient transfection of EL4 cells with a reporter gene under the control of multiple IL-2 distal NF-AT motifs exhibited increased transcriptional activity by CBN in suboptimally activated cells. In addition, the CBN-mediated enhancement of IL-2 protein secretion and the transcriptional activity of the IL-2 distal NF-AT reporter gene was abrogated by the calcium/calmodulin-dependent protein kinase inhibitor KN93, but not by the CB2 receptor antagonist SR144528. Enhancement of IL-2 was also demonstrated with CP55940, Delta(9)-tetrahydrocannabinol, and cannabidiol, thus suggesting that the phenomenon is not unique to CBN. Collectively, these results suggest that increased IL-2 secretion by CBN is mediated through the enhancement of IL-2 gene transcription by activation of NF-AT in a CB1/CB2-independent manner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809870     DOI: 10.1124/mol.61.2.446

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

1.  Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.

Authors:  Thitirat Ngaotepprutaram; Barbara L F Kaplan; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-30       Impact factor: 4.219

2.  Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol.

Authors:  Weimin Chen; Robert B Crawford; Barbara L F Kaplan; Norbert E Kaminski
Journal:  J Neuroimmune Pharmacol       Date:  2015-04-22       Impact factor: 4.147

3.  Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120.

Authors:  Weimin Chen; Barbara L F Kaplan; Schuyler T Pike; Lauren A Topper; Nicholas R Lichorobiec; Steven O Simmons; Ram Ramabhadran; Norbert E Kaminski
Journal:  J Leukoc Biol       Date:  2012-08-16       Impact factor: 4.962

4.  Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation.

Authors:  Saphala Dhital; John V Stokes; Nogi Park; Keun Seok Seo; Barbara L F Kaplan
Journal:  Cell Immunol       Date:  2016-11-09       Impact factor: 4.868

5.  Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol.

Authors:  Haitian Lu; Barbara L F Kaplan; Thitirat Ngaotepprutaram; Norbert E Kaminski
Journal:  J Leukoc Biol       Date:  2008-11-06       Impact factor: 4.962

6.  Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.

Authors:  Alison E B Springs; Peer W F Karmaus; Robert B Crawford; Barbara L F Kaplan; Norbert E Kaminski
Journal:  J Leukoc Biol       Date:  2008-09-12       Impact factor: 4.962

7.  Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors.

Authors:  Toby K Eisenstein; Joseph J Meissler; Qiana Wilson; John P Gaughan; Martin W Adler
Journal:  J Neuroimmunol       Date:  2007-07-19       Impact factor: 3.478

8.  Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice.

Authors:  Peer W F Karmaus; James G Wagner; Jack R Harkema; Norbert E Kaminski; Barbara L F Kaplan
Journal:  J Immunotoxicol       Date:  2012-11-23       Impact factor: 3.000

Review 9.  "The Two Sides of the Same Coin"-Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained.

Authors:  Mona Khoury; Idan Cohen; Gil Bar-Sela
Journal:  Pharmaceutics       Date:  2022-02-10       Impact factor: 6.321

10.  SARs for the Antiparasitic Plant Metabolite Pulchrol. Part 2: B- and C-Ring Substituents.

Authors:  Paola Terrazas; Sophie Manner; Olov Sterner; Marcelo Dávila; Alberto Giménez; Efrain Salamanca
Journal:  Molecules       Date:  2020-10-01       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.